why choose us

First received: October 27, 2022

Clinical Trial: A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Peanut Allergy

Study Type: INTERVENTIONAL


Official Title: A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

Brief Summary: The overall aims of this study are to demonstrate that treatment with PVX108 immunotherapy has an acceptable safety profile and is effective for reducing clinical reactivity to peanut protein in children and adolescents with peanut allergy.

Read more